Price T Rowe Associates Inc Brainstorm Cell Therapeutics Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.2 - $2.08 $5,100 - $53,040	-25,500 Reduced 37.95%	41,700 $9,000
Q2 2023 Aug 14, 2023	SELL	$2.0 - $3.2 $81,600 - $130,560	-40,800 Reduced 37.78%	67,200 $139,000
Q3 2022 Nov 14, 2022	BUY	$2.55 - $4.42 $38,250 - $66,300	15,000 Added 16.13%	108,000 $478,000
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $87,774 - $116,935	-29,161 Reduced 23.87%	93,000 $353,000
Q1 2021 May 17, 2021	BUY	$3.46 - $7.88 $347,228 - $790,797	100,355 Added 460.22%	122,161 $468,000
Q4 2020 Feb 16, 2021	BUY	$3.99 - $17.73 $87,005 - $386,620	21,806 New	21,806 $99,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.